News and Updates

Curavit acquires Lindus Health CRO assets to accelerate global clinical trials and improve operational efficiency for life science sponsors. Read more here.

Discover how patients and families are turning to innovative clinical trials to access groundbreaking treatments and advance the future of medicine.

New research explores the elusive non-clinical factors influencing FDA drug approvals, highlighting the need for better transparency in regulatory decisions.

Swedish researchers have developed a 3D computational model to map snoring mechanics, offering new insights into airway obstruction and sleep apnea treatment.

Amylyx Pharmaceuticals moves toward FDA approval for avexitide after successful clinical trials for metabolic disorders. Learn about the trial results here.

India’s CDSCO has directed Lupin to modify its Phase III clinical trial protocol for biosimilar Insulin Degludec, prioritizing patient safety and efficacy.

Craif has secured $33 million to launch a U.S. clinical trial for a groundbreaking urine-based test designed to detect pancreatic cancer early.

Pila Pharma receives regulatory approval to begin clinical trials for its obesity drug XEN-D0501. Explore how this TRPV1 antagonist could reshape metabolic care.

Lynch Regenerative Medicine hits a major milestone by completing enrollment for its Phase II clinical trial, moving closer to breakthrough therapy results.

The NIH’s recent funding cuts threaten the future of clinical research by eliminating key training programs for trialists—risking a decade of progress.